US MA Needham Kropp L: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) No edit summary Tag: Reverted |
Beno Marija (talk | contribs) No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 13: | Line 13: | ||
== Collaboration == | |||
:::* [[Brown David A]] is supervisor of [[Kropp Laura]] | :::* [[Brown David A]] is supervisor of [[Kropp Laura]] | ||
[[Category:Power-O2k]] |
Latest revision as of 16:22, 3 November 2022
US MA Needham Kropp L
O2k-Network Lab | Stealth BioTherapeutics, US |
---|---|
Address | 140 Kendrick Street, Building C-West, 02494 |
City | Needham |
State/Prov | Massachusetts (MA) |
Country | USA |
Weblink | https://www.stealthbt.com/ |
Contact | Kropp Laura, Brown David A |
Team | Handler Alyssa |
Team previous | |
Status | 2 Power-O2k 2021- |
Oroboros Events | |
Topics |
O2k-Publications
Published | Reference | |
---|---|---|
Bandara 2021 BMC Mol Cell Biol | 2021 | Bandara AB, Drake JC, Brown DA (2021) Complex II subunit SDHD is critical for cell growth and metabolism, which can be partially restored with a synthetic ubiquinone analog. https://doi.org/10.1186/s12860-021-00370-w |
Hamm 2021 Mol Ther Methods Clin Dev | 2021 | Hamm SE, Fathalikhani DD, Bukovec KE, Addington AK, Zhang H, Perry JB, McMillan RP, Lawlor MW, Prom MJ, Vanden Avond MA, Kumar SN, Coleman KE, Dupont JB, Mack DL, Brown DA, Morris CA, Gonzalez JP, Grange RW (2023) Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice. https://doi.org/10.1016/j.omtm.2021.02.024 |
O2k-Abstracts
update please
Collaboration
- Brown David A is supervisor of Kropp Laura